President-elect Trump's steadfast backing of Robert F. Kennedy Jr.'s nomination for Health and Human Services Secretary, coupled with the incoming Republican Senate majority, anchors trader consensus at 74.5% against his removal or withdrawal by December 31. Recent developments include RFK Jr.'s constructive meetings with senators like Rand Paul and Marsha Blackburn, signaling potential bipartisan paths despite vaccine policy pushback from figures like Bill Cassidy. No official signals of nomination reversal have emerged, and the confirmation hearing scheduled for early December leaves ample time for Senate approval before year-end. Markets reflect skin-in-the-game bets on GOP loyalty prevailing over opposition, though abrupt scandals remain a tail risk.
Resumen experimental generado por IA con datos de Polymarket · ActualizadoAn announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Mercado abierto: Mar 19, 2026, 2:02 PM ET
Resolver
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...President-elect Trump's steadfast backing of Robert F. Kennedy Jr.'s nomination for Health and Human Services Secretary, coupled with the incoming Republican Senate majority, anchors trader consensus at 74.5% against his removal or withdrawal by December 31. Recent developments include RFK Jr.'s constructive meetings with senators like Rand Paul and Marsha Blackburn, signaling potential bipartisan paths despite vaccine policy pushback from figures like Bill Cassidy. No official signals of nomination reversal have emerged, and the confirmation hearing scheduled for early December leaves ample time for Senate approval before year-end. Markets reflect skin-in-the-game bets on GOP loyalty prevailing over opposition, though abrupt scandals remain a tail risk.
Resumen experimental generado por IA con datos de Polymarket · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes